Sedentary Lifestyle Trends Fueling Growth In The Muscle Wasting Disorders Market: Powering Innovation and Expansion in the Muscle Wasting Disorders Market by 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

What Is the Expected CAGR for the Muscle Wasting Disorders Market Through 2025?
The market size of muscle wasting disorders has seen quick expansion in the last few years. There will be an increase from $15.06 billion in 2024 to $17.54 billion in 2025, marking a compound annual growth rate (CAGR) of 16.5%. The reasons behind this growth during the historic period include a rise in the aging population, an increased occurrence of chronic diseases, advances in the field of research and development, heightened consciousness about early diagnostics, and the appearance of novel therapeutic methods.

What's the Projected Size of the Global Muscle Wasting Disorders Market by 2029?
The market for muscle wasting disorders is projected to experience a swift expansion in the upcoming years. The market size is forecasted to reach $29.67 billion by 2029, growing at a compound annual growth rate (CAGR) of 14.1%. The anticipated growth can be credited to factors such as regulatory support, healthcare infrastructure advancements, globalization of clinical trials, patient advocacy initiatives, and personalized medicine strategies. Dominant trends for the period include the uptake of telemedicine, product innovation, strategic collaborations and partnerships, advancement in therapeutics and diagnostics technology, research into molecular mechanisms, and innovation in the biopharmaceutical field.

View the full report here:
https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

Top Growth Drivers in the Muscle Wasting Disorders Industry: What's Accelerating the Market?
The growth of the muscle wasting disorders market is expected to be fueled by the increasing prevalence of a sedentary lifestyle. This term refers to a way of life marked by a lack of physical activity or exercise. Such a lifestyle can have harmful effects on muscle function, leading to a reduction in muscle strength and stamina, triggering muscle wasting disorders, and posing difficulties for individuals in retaining their muscular mass and function. For example, the World Health Organization, an intergovernmental organization headquartered in Switzerland, reported in 2022 that over 80% of adolescents and 27% of adults didn't meet the physical activity standards recommended by them. Consequently, the rampant rise in the adoption of a sedentary lifestyle is stimulating the growth of the muscle wasting disorders market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

What Trends Will Shape the Muscle Wasting Disorders Market Through 2029 and Beyond?
Leading corporations in the muscle wasting disorders market are pursuing the creation of novel products, such as innovative gene therapy, intended to enhance treatment for patients affected by muscle wasting disorders. The term novel gene therapy pertains to a scientific advancement designed to effect healing by manipulating gene expression or changing the biological characteristics of living cells. For example, Sarepta Therapeutics, an American biotechnology organization, launched Elevidys in June 2023. It is the inaugural gene therapy approved by the U.S. Food and Drug Administration (FDA) geared towards the treatment of Duchenne muscular dystrophy (DMD) in pediatric patients aged between 4 to 5 years. Elevidys is a sort of recombinant gene therapy, contrived to introduce into the body a gene that results in a truncated protein with selected elements of the dystrophin protein found in normal muscle cells. The product is dispensed through a single intravenous infusion.

What Are the Main Segments in the Muscle Wasting Disorders Market?
The muscle wasting disorders market covered in this report is segmented -

1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types
2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types
3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

Subsegments:
1) By Medications: Anabolic Steroids, Hormonal Treatments, Anti-Inflammatory Drugs, Immunomodulatory Agents
2) By Physical Therapy: Resistance Training, Stretching Exercises, Aerobic Conditioning, Rehabilitation Programs
3) By Nutritional Therapy: Protein Supplements, Nutritional Counseling, Dietary Modifications, Micronutrient Supplements
4) By Surgery: Surgical Interventions For Muscle Repair, Orthopedic Surgeries, Procedures For Underlying Conditions
5) By Gene Therapy: Gene Replacement Therapy, CRISPR-Based Approaches, RNA Interference Techniques
6) By Other Treatment Types: Complementary Therapies, Psychological Support, Assistive Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13706&type=smp

Which Top Companies are Driving Growth in the Muscle Wasting Disorders Market?
Major companies operating in the muscle wasting disorders market report are Pfizer Inc., F. Hoffmann-La Roche Ltd., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline (GSK), Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, Acceleron Pharma Inc., Biogen Inc., Santhera Pharmaceuticals Holding AG, Mitsubishi Tanabe Pharma, Nippon Shinyaku Co. Ltd. (NS Pharma, Inc.), Sarepta Therapeutics Inc., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Axogen, Inc., FibroGen Inc., Cytokinetics Incorporated, Italfarmaco S.p.A., Scholar Rock, Bellerophon Therapeutics, Akashi Therapeutics, aTyr Pharma, Metabolic Solutions Development Company, Synaptogenix, MyoKardia, Inc., MyoTherix Inc.

Which Regions Will Dominate the Muscle Wasting Disorders Market Through 2029?
North America was the largest region in the muscle wasting disorder market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13706

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.